PRODUCT DETAIL

Flixonase Nasal Drops

Code

06513

MA number

69/0116/01-S

Product Form:

int nas 28(4x7)x400 µg (obal PE jednodávkový)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

National

MAH, country:

GlaxoSmithKline Trading Services Limited, Ireland

Therapeutic Class:

69 - OTORHINOLARYNGOLOGICA

ATC:

R	RESPIRATORY SYSTEM
R01	NASAL PREPARATIONS
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01AD	Corticosteroids
R01AD08	Fluticasone

Shelf life:

Container:

container PE

Route of admin.:

Nasal use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 8(3) application - known active substance
MA issued:	04.04.2001
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
SPC:	SPC_Flixonase nasal drops_03.2021.pdf
PIL:	PIL_Flixonase nasal drops_03.2021.pdf
Safety feature	Yes
Data update:	22.05.2018